Compare BNTC & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTC | FEIM |
|---|---|---|
| Founded | 1995 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.4M | 439.6M |
| IPO Year | 2020 | 1994 |
| Metric | BNTC | FEIM |
|---|---|---|
| Price | $12.50 | $57.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $27.67 | ★ $51.50 |
| AVG Volume (30 Days) | 97.6K | ★ 141.1K |
| Earning Date | 05-14-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 80.94 | ★ 316.95 |
| EPS | N/A | ★ 0.41 |
| Revenue | N/A | ★ $69,811,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $21.73 |
| P/E Ratio | ★ N/A | $136.80 |
| Revenue Growth | N/A | ★ 26.30 |
| 52 Week Low | $9.85 | $16.77 |
| 52 Week High | $17.15 | $61.47 |
| Indicator | BNTC | FEIM |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 57.59 |
| Support Level | $11.39 | $41.43 |
| Resistance Level | $13.27 | $59.75 |
| Average True Range (ATR) | 0.65 | 3.74 |
| MACD | -0.10 | 0.23 |
| Stochastic Oscillator | 38.70 | 81.11 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.